The potassium channel opener NS1619 modulates calcium homeostasis in muscle cells by inhibiting SERCA

Cell Calcium

Volumn 56, Issue 1, 2014, Pages 14-24

  Wrzosek, Antoni ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Calcium homeostasis; NS1619; Potassium channels; Sarcoplasmic reticulum

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ADENOSINE TRIPHOSPHATASE; CALCIUM ION; FURA 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; CALCIUM; BENZIMIDAZOLE DERIVATIVE; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLUORESCENCE; GUINEA PIG; HEART CONTRACTION; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; CELL PH; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG TARGETING; HEART PAPILLARY MUSCLE; MUSCLE CONTRACTION; PH MEASUREMENT; SARCOPLASMIC RETICULUM; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; HOMEOSTASIS; ISCHEMIA; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY;

CAVIA; RATTUS;

ANIMALS; BENZIMIDAZOLES; CALCIUM; CELL LINE; GUINEA PIGS; HOMEOSTASIS; ISCHEMIA; MICE; MUSCLE CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; POTASSIUM CHANNELS; RATS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84901986951     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.03.005     Document Type: Article

References (52)

1. + channels are involved in ischemic postconditioning in rat hearts. J. Physiol. Sci. 2012, 62:325-332.
2. Ca channel opener, in vascular smooth muscle. Br. J. Pharmacol. 1994, 113:1538-1547.
3. Gribkoff V.K., Lum-Ragan J.T., Boissard C.G., Post-Munson D.J., Meanwell N.A., Starrett J.E., Kozlowski E.S., Romine J.L., Trojnacki J.T., McKay M.C., Zhong J., Dworetzky S.I. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol. Pharmacol. 1996, 50:206-217.
4. Ca channel activator, NS1619, on rat cerebral artery smooth muscle. Br. J. Pharmacol. 1996, 117:119-129.
5. Hu S., Kim H.S. On the mechanism of the differential effects of NS004 and NS1608 in smooth muscle cells from guinea pig bladder. Eur. J. Pharmacol. 1996, 318:461-468.
6. McKay M.C., Dworetzky S.I., Meanwell N.A., Olesen S.P., Reinhart P.H., Levitan I.B., Adelman J.P., Gribkoff V.K. Opening of large-conductance calcium-activated potassium channels by the substituted benzimidazolone NS004. J. Neurophysiol. 1994, 71:1873-1882.
7. + channels by novel benzimidazolone. Eur. J. Pharmacol. 1994, 251:53-59.
8. Cui J., Yang H., Lee U.S. Molecular mechanisms of BK channel activation. Cell Mol. Life Sci. 2009, 66:852-875.
9. Ghatta S., Nimmagadda D., Xu X., O'Rourke S.T. Large-conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol. Ther. 2006, 110:103-116.
10. + channels in arteriolar muscle cells. Am. J. Physiol. 1998, 274:H27-H34.
11. Eichhorn B., Dobrev D. Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential. Naunyn Schmiedebergs Arch. Pharmacol. 2007, 376:145-155.
12. Feletou M., Verbeuren T.J., Vanhoutte P.M. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br. J. Pharmacol. 2009, 156:563-574.
13. + currents in neurones: types, physiological roles and modulation. Trends Neurosci. 1996, 19:150-154.
14. Runden-Pran E., Haug F.M., Storm J.F., Ottersen O.P. BK channel activity determines the extent of cell degeneration after oxygen and glucose deprivation: a study in organotypical hippocampal slice cultures. Neuroscience 2002, 112:277-288.
15. 2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem. Biophys. Res. Commun. 1999, 257:549-554.
16. Szewczyk A., Jarmuszkiewicz W., Kunz W.S. Mitochondrial potassium channels. IUBMB Life. 2009, 61:134-143.
17. Gaspar T., Domoki F., Lenti L., Katakam P.V., Snipes J.A., Bari F., Busija D.W. Immediate neuronal preconditioning by NS1619. Brain Res. 2009, 1285:196-207.
18. 2+ channels in rat ventricular myocytes. Biochem. Biophys. Res. Commun. 2007, 362:31-36.
19. + channel modulators NS1619 [1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2 H-benzimidazol-2-one] and isopimaric acid. J. Pharmacol. Exp. Ther. 2007, 321:1075-1084.
20. + channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells. Biochem. Pharmacol. 2003, 65:1827-1834.
21. + influx increases respiration and enhances ROS production while maintaining membrane potential. Am. J. Physiol. Cell Physiol. 2007, 292:C148-C156.
22. + channel activity in isolated heart mitochondria. Cardiovasc. Res. 2007, 73:720-728.
23. Ca channel. J. Cell. Physiol. 2011, 226:1660-1675.
24. 2+ in CD34+ cell line KG-1a. Exp. Hematol. 2003, 31:815-823.
25. 2+ release in smooth muscle cells of porcine coronary artery. Br. J. Pharmacol. 2001, 132:828-834.
26. +-channel opener NS1619 increases endothelial NO-synthesis involving p42/p44 MAP-kinase. Thromb. Haemost. 2004, 92:1099-1107.
27. + channel opening. Am. J. Physiol. Cell Physiol. 2010, 298:C530-C541.
28. Mulieri L.A., Hasenfuss G., Ittleman F., Blanchard E.M., Alpert N.R. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ. Res. 1989, 65:1441-1449.
29. Chu A., Dixon M.C., Saito A., Seiler S., Fleischer S. Isolation of sarcoplasmic reticulum fractions referable to longitudinal tubules and junctional terminal cisternae from rabbit skeletal muscle. Methods Enzymol. 1988, 157:36-46.
30. 3H]ryanodine binding. Biochim. Biophys. Acta 1998, 1404:435-450.
31. Wrzosek A., Schneider H., Grueninger S., Chiesi M. Effect of thapsigargin on cardiac muscle cells. Cell Calcium 1992, 13:281-292.
32. 2+ uptake by the cardiac sarcoplasmic reticulum. Pflugers Arch. 2000, 440:573-579.
33. + channel opener CGS7184 as a regulator of endothelial cell function. Eur. J. Pharmacol. 2009, 602:105-111.
34. Inesi G., Kurzmack M., Coan C., Lewis D.E. Cooperative calcium binding and ATPase activation in sarcoplasmic reticulum vesicles. J. Biol. Chem. 1980, 255:3025-3031.
35. 2+ release from the endoplasmic reticulum. Eur. J. Pharmacol. 2012, 690:60-67.
36. 2+ concentration after length changes in isolated rat ventricular trabeculae. J. Physiol. 1998, 506:431-444.
37. Ca-channel activity in human cardiac fibroblasts to electrical coupling of cardiomyocytes-fibroblasts. J. Membr. Biol. 2006, 213:175-185.
38. Brini M., Carafoli E. Calcium pumps in health and disease. Physiol. Rev. 2009, 89:1341-1378.
39. Wuytack F., Raeymaekers L., Missiaen L. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium. 2002, 32:279-305.
40. Hoch B., Haase H., Schulze W., Hagemann D., Morano I., Krause E.G., Karczewski P. Differentiation-dependent expression of cardiac delta-CaMKII isoforms. J. Cell Biochem. 1998, 68:259-268.
41. Ihara Y., Kageyama K., Kondo T. Overexpression of calreticulin sensitizes SERCA2a to oxidative stress. Biochem. Biophys. Res. Commun. 2005, 329:1343-1349.
42. Winther A.-M.L., Bublitz M., Karlsen J.L., Moller J.V., Hansen J.B., Nissen P., Buch-Pedersen M.J. The sarcolipin-bound calcium pump stabilizes calcium sites exposed to the cytoplasm. Nature 2013, 495:265-269.
43. 2+-ATPase. J. Biol. Chem. 1998, 273:12360-12369.
44. Gorski P.A., Glaves J.P., Vangheluwe P., Young H.S. Sarco(endo)plasmic reticulum calcium ATPase (SERCA) inhibition by sarcolipin is encoded in its luminal tail. J. Biol. Chem. 2013, 288:8456-8467.
45. Endo M. Calcium-induced calcium release in skeletal muscle. Physiol. Rev. 2009, 89:1153-1176.
46. Wray S., Burdyga T. Sarcoplasmic reticulum function in smooth muscle. Physiol. Rev. 2010, 90:113-178.
47. Yao H., Haddad G.G. Calcium and pH homeostasis in neurons during hypoxia and ischemia. Cell Calcium 2004, 36:247-255.
48. Lee J.W., Lee H.K., Kim H.W., Kim Y.-H. Effects of pH, buffer system and lactate on the simulated ischemia-reperfusion injury of H9c2 cardiac myocytes. Kor. J. Physiol. Pharmacol. 2007, 11:45-55.
49. 2+-signalling to intracellular pH. J. Mol. Cell. Cardiol. 2013, 61:51-59.
50. Dennis S.C., Gevers W., Opie L.H. Protons in ischemia: Where do they come from; Where do they go to. J. Mol. Cell Cardiol. 1991, 23:1077-1086.
51. Garlick P.B., Radda G.K., Seeley P.J. Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance. Biochem. J. 1979, 184:547-554.
52. Ca is encoded by the Kcnma1 gene, and a splicing sequence defines its mitochondrial location. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:10836-10841.